Citation data
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
14 resultsUpdated September 23, 2026
1
Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates
Transplantation and Cellular Therapy
May 2026
Feng A.
2
Application of small interfering RNAs and drug combination for pancreatic cancer therapy
Journal of Drug Targeting
2026
Zeng C.
3
Advances in applications of siRNA in cancer therapy: challenges and opportunities
Clinical and Translational Oncology
2026
Mehrparvar M.
4
Blood expression of CTLA-4, PD-1, and PD-L1 as potential prognostic and diagnostic markers for breast cancer: a systematic review
Discover Oncology
December 2025
Niusha M.
Open Access
5
Association of the SLC6A3 Gene rs2652511 Polymorphism with Methamphetamine Abuse Disorder in the Iranian Population
Addiction and Health
2025
Khosroshahi M.A.
Open Access
6
Influence of CAR T-cell therapy associated complications
Frontiers in Oncology
2025
Umair M.M.
Open Access
7
Outcomes of physical exercises on initiation, progression, and treatment of breast cancer
Cell Communication and Signaling
May 2024
Xu J.
Open Access
8
Isolation and characterization of a novel single-chain variable fragment (scFv) against Lymphocyte function-associated antigen-1 (LFA-1) using phage display method
Medical Oncology
January 2024
Afsharnoori F.
9
Application of Engineered Dendritic Cell Vaccines in Cancer Immunotherapy: Challenges and Opportunities
Current Treatment Options in Oncology
December 2023
Li P.
10
Apatinib increases anticancer potential of doxorubicin in breast cancer cells
Molecular Biology Reports
December 2023
Aghaei E.
11
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities
Molecular Biology Reports
November 2023
Isazadeh H.
12
Knockdown of SIX4 inhibits pancreatic cancer cells via apoptosis induction
Medical Oncology
October 2023
Heiat M.
13
14
Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance study
Immunotherapy
1 April 2023
Zhai Y.